Suppr超能文献

超越阳性症状的思考与行动:认知症状和阴性症状在精神分裂症中的作用

Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia.

作者信息

Carbon Maren, Correll Christoph U

机构信息

1Psychiatry Research,The Zucker Hillside Hospital,North Shore-Long Island Jewish Health System,Glen Oaks,New York,USA.

出版信息

CNS Spectr. 2014 Dec;19 Suppl 1:38-52; quiz 35-7, 53. doi: 10.1017/S1092852914000601. Epub 2014 Nov 18.

Abstract

Since currently available antipsychotic medications predominantly treat hallucinations, delusions, disorganized thoughts and behavior, and related agitation/aggression, attention has traditionally been focused on managing positive symptoms. However, prominent negative symptoms and clinically relevant cognitive impairment affect approximately 40% and 80% of people with schizophrenia, respectively. Moreover, negative and cognitive symptoms are closely related to functional outcomes, and contribute substantially to the overall illness burden. Therefore, approaches to describe, measure, and manage these symptom domains are relevant. This article summarizes the phenomenology, prevalence, assessment, and treatment of negative and cognitive symptoms in patients with schizophrenia, including pharmacologic and nonpharmacologic management strategies that can be used in clinical care now, as well as pharmacologic approaches that are being tested. Currently, no approved treatments targeting negative or cognitive symptomatology in schizophrenia are available. It is hoped that progress in the understanding of the neurobiology of these important symptom domains of schizophrenia will help develop effective treatment strategies in the future. However, until this goal is achieved, clinicians should avoid therapeutic nihilism. Rather, the severity and impact of negative and cognitive symptoms should be determined, quantified, and monitored. Further, psychosocial treatments have shown therapeutic benefits. Thus, cognitive behavioral therapy, cognitive remediation, social skills training, and computer-assisted training programs should be offered in conjunction with antipsychotic treatment. Several non-antipsychotic augmentation strategies can be tried off-label. Treatment plans that incorporate currently available management options for negative and cognitive symptomatology in patients with schizophrenia should be adapted over time and based on the individual's needs, with the aim to enhance overall outcomes.

摘要

由于目前可用的抗精神病药物主要用于治疗幻觉、妄想、思维紊乱和行为以及相关的激越/攻击行为,传统上注意力一直集中在管理阳性症状上。然而,显著的阴性症状和临床上相关的认知障碍分别影响约40%和80%的精神分裂症患者。此外,阴性症状和认知症状与功能结局密切相关,并在很大程度上导致了整体疾病负担。因此,描述、测量和管理这些症状领域的方法具有重要意义。本文总结了精神分裂症患者阴性和认知症状的现象学、患病率、评估和治疗,包括目前可用于临床护理的药物和非药物管理策略,以及正在进行测试的药物治疗方法。目前,尚无批准用于治疗精神分裂症阴性或认知症状的药物。希望在对精神分裂症这些重要症状领域的神经生物学理解方面取得的进展将有助于在未来开发有效的治疗策略。然而,在实现这一目标之前,临床医生应避免治疗虚无主义。相反,应确定、量化和监测阴性和认知症状的严重程度及影响。此外,心理社会治疗已显示出治疗益处。因此,应将认知行为疗法、认知矫正、社交技能训练和计算机辅助训练项目与抗精神病药物治疗联合使用。可以尝试几种非抗精神病药物的增效策略,但属于超说明书用药。针对精神分裂症患者阴性和认知症状的现有管理方案的治疗计划应随着时间推移并根据个体需求进行调整,以提高总体治疗效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验